15-12G ยทFiled May 7, 2026
Deregistration
Actionable Insight โข Neutral
The deregistration is a procedural step post-merger. FOLD shares will cease to be publicly traded. No further trading action is expected.
Price Chart
Loading chart...
Executive Summary
Amicus Therapeutics filed a Form 15-12G to deregister its securities following its acquisition by BioMarin Pharmaceutical. The merger closed on April 27, 2026, leaving Amicus as a wholly owned subsidiary with a single holder of record. This is a routine post-merger deregistration.
Key Facts
- Effective April 27, 2026, Amicus merged with a subsidiary of BioMarin Pharmaceutical Inc.
- Amicus survives as a wholly owned subsidiary of BioMarin.
- Number of holders of record as of certification date: one (1).
- Deregistration filed under Rule 12g-4(a)(1).
Financial Impact
No new financial impact; deregistration follows a completed acquisition.
Risk Factors
- Remaining minority shareholders may face illiquidity if any shares not cashed out.
- No further SEC filings will be made by the company.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
43% bullish (14 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 15-12G Filing (Primary) | 0001140361-26-019442 |
| Document: 0001140361-26-019442-index-headers.html | 0001140361-26-019442 |
| Document: 0001140361-26-019442-index.html | 0001140361-26-019442 |
| Document: 0001140361-26-019442.txt | 0001140361-26-019442 |
3 reports for FOLD
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
May 7, 2026 21w ago | 15-12G | โ | awaiting T+1 | โ | โ |
Apr 27, 2026 22w ago | 8-K | $14.49 $14.49 | ยท 0.00% | โฒ +0.49% | โ |
Apr 23, 2026 23w ago | 8-K | $14.49 $14.49 | ยท 0.00% | โผ โ0.16% | โ |
Showing 3 of 3
US Market Status
Market Open โ Closes in 42m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access